Dyax
This article was originally published in The Gray Sheet
Executive Summary
Exercise of a 600,000-share underwriter overallotment option increases initial public offering gross proceeds to $69 mil. All together, the biopharmaceutical company's IPO consisted of 4.6 mil. shares at $15 each (1"The Gray Sheet" Aug. 21, 2000, p. 11). J.P. Morgan & Co. was lead manager for the offering, with Lehman Brothers and Pacific Growth Equities acting as co-managers